JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Volatile Organic Metabolites as Potential Biomarkers for Genitourinary Cancers: Review of the Applications and Detection Methods

  • 0Department of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX 79968, USA.
Metabolites +

|

January 24, 2025

|

January 24, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Volatile organic compounds (VOCs) show promise for early cancer detection in genitourinary cancers. Analyzing VOCs in samples like urine could lead to new, non-invasive diagnostic tools for kidney, prostate, bladder, and testicular cancers.

Area Of Science

  • Oncology
  • Metabolomics
  • Biomarker Discovery

Background

  • Cancer is a leading global cause of death, with early detection critical for improved outcomes.
  • Genitourinary cancers present unique early detection challenges, necessitating novel diagnostic approaches.
  • Volatile organic compounds (VOCs), as metabolic byproducts, offer potential for non-invasive cancer detection.

Purpose Of The Study

  • To review the current state of genitourinary cancers (kidney, prostate, bladder, testicular).
  • To explore the application of VOCs as biomarkers for genitourinary cancer detection.
  • To examine analytical techniques for VOC detection and their potential in oncology.

Main Methods

  • Review of current literature on genitourinary cancers, epidemiology, and diagnostics.
  • Analysis of VOCs as biomarkers across various biospecimens (urine, breath, blood).
  • Comparison of different VOC extraction and detection methodologies.

Main Results

  • VOC analysis presents a promising avenue for sensitive and non-invasive early cancer detection.
  • Standardized methods for VOC detection and analysis are still under development.
  • VOCs may aid in monitoring disease progression and treatment response in genitourinary oncology.

Conclusions

  • VOC-based diagnostics hold significant potential for revolutionizing early detection of genitourinary cancers.
  • Further research is needed to overcome challenges in robust VOC detection and standardization.
  • This approach could enhance patient outcomes and reduce healthcare burdens through timely intervention.

Keywords: